Clinical Trials Directory

Trials / Conditions / Migraine Without Aura

Migraine Without Aura

88 registered clinical trials studyying Migraine Without Aura12 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingApp-Based Migraine Treatment: The Health enSuite Study
NCT06797076
IWK Health CentreN/A
Not Yet RecruitingMyotensive Extraocular Muscle Techniques Added to Manual Therapy for Migraine Without Aura
NCT07254598
Facultad de Enfermería, Fisioterapia y Podología (FEFP)N/A
Not Yet RecruitingEfficacy and Mechanism of Fu's Subcutaneous Needling Treatment for Migraine Without Aura
NCT07068815
Guangzhou University of Chinese MedicinePhase 1
WithdrawnHealthy Living Partnerships for Veterans With Migraine
NCT04373330
Wake Forest University Health SciencesN/A
RecruitingTrial Designs for Evaluating Migraine Treatment
NCT06617832
University of AarhusN/A
Active Not RecruitingItalian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine P
NCT06414044
University of Florence
RecruitingEffectiveness and Tolerability of Eptinezumab
NCT06409845
University of Florence
RecruitingRimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
NCT06409832
University of Florence
CompletedMi-Helper Transnasal Cooling for Acute Treatment of Migraine
NCT06051604
CoolTech LLCN/A
UnknownAnisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine
NCT05416476
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 3
RecruitingMigraine Attack Pain Phase Prediction Study
NCT06459635
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
RecruitingResponding With Evidence and Access for Childhood Headaches
NCT05889624
Children's Hospital Medical Center, CincinnatiN/A
CompletedMigraine With and Without Aura Characteristics and Response to Remote Electrical Neuromodulation (REN) Treatme
NCT06023953
Theranica
CompletedDitan Acute tReatments: Effectiveness and Tolerability (DART)
NCT05903040
University of Florence
RecruitingGepant treAtments: EffectIveNess and tolERability (GAINER)
NCT05903027
University of Florence
RecruitingTIzanidine for the Preventive Treatment of Episodic MigrainE (TIME)
NCT05484349
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 3
CompletedEffect of Riocigaut on Migraine Attack Induction in People With Migraine
NCT05750446
Danish Headache CenterN/A
CompletedEffect of Sildenafil in Individuals With Migraine Pretreated With Erenumab
NCT05889455
Danish Headache CenterN/A
CompletedEffect of Levcromakalim in Individuals With Migraine Pretreated With Erenumab
NCT05889442
Danish Headache CenterN/A
UnknownThe FreMRI Study: Advanced MRI on Migraine Patients Treated With Fremanezumab
NCT06244823
Hospital Clínico Universitario de ValladolidPhase 4
UnknownTailored Digital Treatment for Migraine
NCT05617339
Vastra Gotaland RegionN/A
RecruitingMolecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
NCT06674772
Hospital Universitari Vall d'Hebron Research Institute
UnknownMonoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study
NCT05281770
Austrian Migraine Registry Collaboration
UnknownThe Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain.
NCT05565001
Danish Headache CenterN/A
TerminatedEvaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine
NCT05214001
Messoud Ashina, MDPhase 4
UnknownBrain Connectome for Acupuncture-treated Migraine Patients
NCT04157192
Centre Hospitalier Universitaire de NīmesN/A
TerminatedEvaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine
NCT05211154
Danish Headache CenterPhase 4
UnknownOptical Coherence Tomography Findings in Migraine
NCT05332431
Assiut University
CompletedEffect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine
NCT05211050
Danish Headache CenterN/A
TerminatedTransnasal Cooling for Migraine
NCT04936061
CoolTech LLCN/A
TerminatedEfficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room
NCT04726592
Assistance Publique - Hôpitaux de ParisPhase 3
CompletedDigital Treatment for Migraines - a Feasibility Study
NCT05018572
Vastra Gotaland RegionN/A
CompletedA Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment o
NCT04940390
Satsuma Pharmaceuticals, Inc.Phase 3
CompletedEffect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM)
NCT04853797
Danish Headache CenterN/A
UnknownA Randomized Controlled Trial of Acupuncture in Treating Migraine
NCT04766762
The Third Affiliated hospital of Zhejiang Chinese Medical UniversityN/A
RecruitingMind Body Balance for Pediatric Migraine
NCT04715685
Children's Hospital Medical Center, CincinnatiN/A
CompletedA Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
NCT05337254
Satsuma Pharmaceuticals, Inc.Phase 1
CompletedMigraine STImulation Crisis of Migraine
NCT04568252
Remedee SAN/A
CompletedA Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine
NCT04406649
Satsuma Pharmaceuticals, Inc.Phase 3
CompletedIbuprofen in Migraine Patients
NCT04533568
Kecioren Education and Training HospitalPhase 4
UnknownThe Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Propert
NCT04452929
Danish Headache CenterN/A
CompletedA Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine
NCT03901482
Satsuma Pharmaceuticals, Inc.Phase 3
CompletedThe Effect of Connective Tissue Massage in Patients With Migraine
NCT04171362
Ankara Yildirim Beyazıt UniversityN/A
CompletedA Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy
NCT03874832
Satsuma Pharmaceuticals, Inc.Phase 1
CompletedPACAP38 Induced Headache, Migraine and Flushing in Patients With Migraine
NCT03881644
Danish Headache CenterN/A
UnknownMultiparametric Diagnostic Model of Thick-section Clinical-quality MRI Data in Detecting Migraine Without Aura
NCT03570086
Xidian University
CompletedAmylin and CGRP Head to Head Provocation in Migraine Without Aura Patients
NCT03598075
Danish Headache CenterN/A
CompletedCan DFN-15 Terminate Migraine With Allodynia?
NCT03472378
Hartford HospitalPhase 2
CompletedACT Therapy for HF Migraine
NCT03461874
Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaN/A
CompletedAcupuncture In Migraine Without Aura Patients
NCT04542811
Ataturk UniversityN/A
CompletedEvaluation of a Novel Device for Treatment of Migraine Headache
NCT03361423
TheranicaN/A
CompletedStudy the Effect of Acupuncture on Migraine Patient Without Aura Via Functional Magnetic Resonance Imaging.
NCT04636359
Beijing University of Chinese MedicineN/A
CompletedPACAP27 Headache Properties in Migraine Without Aura Patients
NCT03471039
Danish Headache CenterN/A
CompletedUltrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block
NCT03478735
Mayo ClinicN/A
CompletedIntegrative Migraine Pain Alleviation Through Chiropractic Therapy
NCT03177616
Harvard University Faculty of MedicineN/A
CompletedContinue or Stop Applying Wet Cupping (Al-Hijamah) in Migraine
NCT03479060
Karabuk UniversityN/A
TerminatedUnderstanding the Pathophysiology of Migraine Pain
NCT03026101
Montefiore Medical CenterN/A
CompletedEfficacy Study of Acupuncture in the Prevention of Migraine Without Aura
NCT02765581
Wei WangN/A
CompletedInvestigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI
NCT02549898
Danish Headache CenterN/A
Completed1H Magnetic Resonance Spectroscopy in Migraine Patients
NCT04220606
Leiden University Medical CenterN/A
CompletedThe Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients
NCT02364453
Song GuoN/A
CompletedInvestigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission Tomography
NCT02309606
Danish Headache Center
CompletedPACAP Induced Migraine Attacks in Patients With High and Low Genetic Load
NCT02158221
Danish Headache CenterN/A
CompletedIndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Head
NCT02115269
Abbott
CompletedCGRP Induced Migraine Attacks in Patients With High and Low Genetic Load
NCT01924052
Danish Headache CenterN/A
CompletedImpact of a Nurse for Migraine Management: the IMPACT Project
NCT01804517
Notre-Dame Hospital, Montreal, Quebec, Canada
CompletedIs Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine
NCT01741714
University Hospital, AkershusN/A
CompletedEfficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment
NCT01814189
Shahid Beheshti University of Medical SciencesPhase 3
UnknownInvestigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI
NCT02202486
Glostrup University Hospital, Copenhagen
CompletedAcupuncture for Migraine Prophylaxis
NCT01687660
Li yingN/A
WithdrawnThe Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine
NCT01653522
The Cleveland ClinicN/A
CompletedIntravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department
NCT01596166
University of AlbertaPhase 4
CompletedEffect of PACAP38/VIP on Migraineurs Measured by Magnetic Resonance
NCT01471990
Glostrup University Hospital, CopenhagenN/A
UnknownPreventive Treatment of Episodic and Chronic Migraine
NCT01319825
California Medical Clinic for HeadachePhase 4
CompletedStudy of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura
NCT00959751
NeurAxon Inc.Phase 2
CompletedCandesartan Versus Propranolol for Migraine Prevention
NCT00884663
Norwegian University of Science and TechnologyPhase 2 / Phase 3
TerminatedA Study of a Melatonin Receptor Agonist to Prevent Migraine
NCT00739024
Swedish Medical CenterPhase 2
CompletedDose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
NCT00534560
Minster Research LtdPhase 2
UnknownEfficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine
NCT00285402
Ariston Pharmaceuticals, Inc.Phase 2
CompletedMaxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
NCT00471952
Diamond Headache ClinicPhase 3
CompletedPACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects o
NCT00380263
Danish Headache CenterN/A
CompletedFunctional MRI (fMRI) in CGRP Induced Migraine
NCT00363532
Danish Headache CenterN/A
CompletedTREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)
NCT00387881
GlaxoSmithKlinePhase 3
CompletedEfficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
NCT00311662
Minster Research LtdPhase 2
CompletedStudy to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migra
NCT00123201
Solvay PharmaceuticalsPhase 2
CompletedEvaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
NCT00334178
Lotus PharmaceuticalPhase 3
CompletedEletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study
NCT01859481
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Phase 3
UnknownCortical Reorganisation in Patients With Primary Headache Disorders
NCT00263991
Danish Headache Center